Moreover, this study was aimed at providing a preliminary characterisation of the expression pattern of hENT1, hCNT1, dCK, 5’-NT, CDA, RRM1 and RRM2 in surgical specimens of bladder cancer, in order to find a possible association between gene expression and response to gemcitabine treatment. This evidence concerns the gene DCK and urinary bladder cancer.